
RadNet, Inc.
100
RadNet reported record third quarter 2026 revenue of $638.3 million and raised full-year guidance. The company announced a $350 million acquisition of OnRad, expanding hospital radiology services. Quarterly earnings showed growth with net income and EPS improvements.
- RadNet reported record third quarter 2026 revenue of $638.3 million and raised full-year guidance [N1].
- The company reported sequential quarterly earnings growth with net income of $4.153 million and EPS of $0.05 for Q3 2026 [N2][S2].
- RadNet entered a merger agreement to acquire OnRad, Inc. for $350 million in cash and 5 million shares, expanding hospital radiology services [N7][N8].
- The company has raised guidance multiple times in 2026 following strong quarterly results [N1][N5][N6].
RadNet, Inc. operates as a leading national provider of diagnostic imaging services in the United States, with a network of 418 imaging centers primarily in nine states. Its services include MRI, CT, PET, nuclear medicine, mammography, ultrasound, X-ray, and fluoroscopy, with most centers offering multiple modalities to diversify revenue and reduce reimbursement risk. The company also operates a Digital Health segment that develops AI-powered radiology software solutions to enhance diagnostic accuracy and operational efficiency. RadNet focuses on regional market leadership to leverage operational efficiencies and maintain strong relationships with payors, radiologists, and referring physicians. The company competes on scale, multi-modality offerings, pricing, facility density, and technological advancement. Industry trends impacting RadNet include an aging population driving demand, increased preventive screening, new imaging applications, and integration of AI technologies.
RadNet, Inc. is a leading U.S. provider of diagnostic imaging services operating 418 centers across nine states, offering multi-modality imaging and a Digital Health segment focused on AI-enhanced radiology solutions. The company reported $750.6 million in cash and equivalents and a current ratio of 1.49 as of September 30, 2026. Recent quarterly results include net income of $4.153 million and EPS of $0.05. RadNet achieved record third quarter 2026 revenue of $638.3 million and raised full-year guidance. The company announced a $350 million acquisition of OnRad, expanding hospital radiology services. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
RadNet's extensive network and multi-modality strategy provide diversified revenue streams and operational efficiencies. The integration of AI through its Digital Health segment enhances diagnostic accuracy and workflow efficiency, potentially improving patient outcomes and provider satisfaction. The recent acquisition of OnRad expands hospital radiology services, broadening market reach. Industry trends such as an aging population and increased preventive screening support sustained demand for diagnostic imaging services. RadNet's strong relationships with payors and referring physicians underpin its market position and pricing competitiveness.
RadNet faces competition from independent operators, hospitals, and physician-owned imaging centers, some with greater financial resources that could enable expansion or technology upgrades. Reimbursement pressures and changes in payor policies could adversely affect revenue. The company's reliance on regional market concentration may expose it to localized economic or regulatory risks. Integration risks exist with acquisitions such as OnRad. Technological disruption or slower adoption of AI solutions could impact competitive positioning. Operational challenges in managing a large network and maintaining quality and profitability across centers remain potential risks.
RadNet's competitive moat is anchored in its scale as the largest operator of freestanding outpatient diagnostic imaging centers in the U.S., with 418 centers concentrated in populous regions enabling operational efficiencies and strong local relationships. Its multi-modality service offering differentiates it by providing patients and physicians convenient access to multiple imaging procedures at one location, reducing costs and increasing throughput. The company's diversified payor mix and expertise in managed care contracts mitigate reimbursement risks. Additionally, RadNet's Digital Health segment and AI capabilities enhance diagnostic services and operational workflows, supporting differentiation. Its experienced management team and track record of acquisitions further strengthen its competitive position.
• Competitive Pressure: RadNet competes with independent imaging operators, hospitals, and physician practices that may have greater financial resources, potentially impacting market share and pricing.
• Reimbursement Risk: Changes in reimbursement policies by commercial insurers, Medicare, or Medicaid could adversely affect revenue and profitability.
• Acquisition Integration: The acquisition of OnRad and other businesses carries risks related to integration, cultural alignment, and realization of anticipated benefits.
• Technological Change: Rapid technological advancements or slower adoption of AI and digital health solutions could affect RadNet's competitive advantage.
• Operational Complexity: Managing a large network of centers across multiple states involves operational risks including maintaining quality, regulatory compliance, and cost control.
Business trends: Increasing demand for diagnostic imaging driven by aging population, preventive screening, and AI integration.
Execution milestones: Integration of OnRad acquisition, continued expansion of Digital Health AI capabilities, and maintaining regional market leadership.
Key risks: Competitive pressures, reimbursement changes, acquisition integration challenges, technological disruption, and operational complexity.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- RadNet, Inc. is a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue as of December 31, 2025 [S1].
- The company operates 418 imaging centers across nine states including Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas, and New York, either directly or through hospital and health system joint ventures [S1].
- RadNet's principal business segment is the provision of diagnostic imaging services including MRI, CT, PET, nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and related procedures [S1].
- Most centers offer multi-modality imaging services, providing multiple types of imaging procedures at one location, which diversifies revenue streams and reduces exposure to reimbursement changes [S1].
- RadNet also operates a Digital Health segment that develops and deploys AI suites to enhance radiologist interpretations, led by its DeepHealth subsidiary and including acquisitions such as Aidence Holding B.V. and Quantib B.V. [S1].
- The Digital Health segment includes software solutions like eRad RIS/PACS and DeepHealth OS, which support radiology service line operations from scheduling to referral management [S1].
- The company focuses on developing leading positions in regional markets to leverage operational efficiencies and maintain strong relationships with payors, radiology groups, and referring physicians [S1].
- RadNet's revenue is derived from a diverse mix of payors including commercial insurance, managed care capitated payors, Medicare, and Medicaid, mitigating reimbursement risk [S1].
- The company competes based on reputation, multi-modality offerings, location density, pricing, quality of services, and relationships with healthcare providers [S1].
- RadNet's diagnostic imaging centers are strategically organized into regional networks concentrated in major population centers, enabling operational efficiencies such as scheduling flexibility and resource allocation [S1].
- The company does not provide mobile imaging services but has joint ventures with hospitals to provide and manage diagnostic imaging services [S1].
- Industry trends include increasing demand for diagnostic imaging driven by an aging population, greater consumer awareness of preventive screening, and new effective applications for imaging technology [S1].
- AI is increasingly integrated into medical imaging for image creation, interpretation assistance, and administrative efficiency improvements [S1].
- As of September 30, 2026, RadNet reported cash and equivalents of $750.6 million, current assets of $1.068 billion, current liabilities of $716.6 million, a current ratio of 1.49, and a cash ratio of 1.05 [S2].
- Net income for the quarter ended September 30, 2026 was $4.153 million with basic and diluted EPS of $0.05 [S2].
- Recent news reports RadNet achieved record third quarter 2026 revenue of $638.3 million and raised full-year guidance [N1].
- RadNet announced a $350 million acquisition of OnRad, Inc., expanding hospital radiology services, with the deal involving cash and shares [N7][N8].
- The company has reported sequential quarterly earnings growth and raised guidance multiple times in 2026 [N1][N2][N5][N6].
Generated 2026-11-09
- S1 | 2026-03-02 | 10-K
- S2 | 2026-11-09 | 10-Q
- N1 | 2026-11-09 | www.nasdaq.com | RadNet, Inc. Reports Record Third Quarter 2026 Revenue of $638.3 Million and Raises Full-Year Guidance | https://www.nasdaq.com/articles/radnet-inc-reports-record-third-quarter-2026-revenue-6383-million-and-raises-full-year
- N2 | 2026-11-09 | www.nasdaq.com | RadNet (RDNT) Reports Q3 Earnings: What Key Metrics Have to Say | https://www.nasdaq.com/articles/radnet-rdnt-reports-q3-earnings-what-key-metrics-have-say
- N3 | 2026-11-06 | www.nasdaq.com | Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates | https://www.nasdaq.com/articles/elanco-animal-health-incorporated-elan-q3-earnings-and-revenues-surpass-estimates
- N4 | 2026-11-05 | www.nasdaq.com | Astrana Health, Inc. (ASTH) Q3 Earnings Lag Estimates | https://www.nasdaq.com/articles/astrana-health-inc-asth-q3-earnings-lag-estimates
- N5 | 2026-11-05 | www.nasdaq.com | RadNet (RDNT) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates | https://www.nasdaq.com/articles/radnet-rdnt-q3-earnings-preview-what-you-should-know-beyond-headline-estimates
- N6 | 2026-11-02 | www.nasdaq.com | RadNet (RDNT) Reports Next Week: Wall Street Expects Earnings Growth | https://www.nasdaq.com/articles/radnet-rdnt-reports-next-week-wall-street-expects-earnings-growth
- N7 | 2026-10-28 | www.nasdaq.com | RadNet to Buy ONRAD in $350M Deal, Expanding Hospital Radiology Services | https://www.nasdaq.com/articles/radnet-buy-onrad-350m-deal-expanding-hospital-radiology-services
- N8 | 2026-10-26 | www.nasdaq.com | RadNet, Inc. Enters Merger Agreement to Acquire OnRad, Inc. for $350,000,000 in Cash and 5,000,000 Shares | https://www.nasdaq.com/articles/radnet-inc-enters-merger-agreement-acquire-onrad-inc-350000000-cash-and-5000000-shares
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


